ANTI-TUMOR 1-(X-ARYL)-3,3-DIALKYLTRIAZENES .2. ROLE OF CORRELATION ANALYSIS IN DECISION-MAKING IN DRUG MODIFICATION - TOXICITY QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS OF 1-(X-PHENYL)-3,3-DIALKYLTRIAZENES IN MICE

被引：36

作者：

HANSCH, C

HATHEWAY, GJ

QUINN, FR

GREENBERG, N

机构：

[1] NCI,DIV CANC TREATMENT,MED CHEM & BIOL LAB,PROGRAM DEV THERAPEUT,BETHESDA,MD 20014

[2] NCI,DIV CANC TREATMENT,DRUG EVALUAT BRANCH,PROGRAM DEV THERAPEUT,BETHESDA,MD 20014

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1978年 / 21卷 / 06期

关键词：

D O I：

10.1021/jm00204a013

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：574 / 577

页数：4

共 20 条

[1]

ANDRYSOVA O, 1972, PHYSIOL BOHEMOSLOV, V21, P63

[2]

CLARKE DA, 1955, P SOC EXP BIOL MED, V90, P484

[3] TUMOR INHIBITORY TRIAZENES - STRUCTURAL REQUIREMENTS FOR AN ACTIVE METABOLITE [J].

CONNORS, TA ;

GODDARD, PM ;

MERAI, K ;

ROSS, WCJ ;

WILMAN, DEV .

BIOCHEMICAL PHARMACOLOGY, 1976, 25 (03) :241-246

[4] USE OF CLUSTER-ANALYSIS IN DEVELOPMENT OF STRUCTURE-ACTIVITY RELATIONS FOR ANTITUMOR TRIAZENES [J].

DUNN, WJ ;

GREENBERG, MJ ;

CALLEJAS, SS .

JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (11) :1299-1301

[5]

GERAN RI, 1972, CANCER CHEMOTHER REP, V3

[6]

GERULATH AH, 1974, CANCER RES, V34, P1921

[7]

HANO K, 1968, GANN, V59, P207

[8]

HANSCH C, 1972, Drug Metabolism Reviews, V1, P1, DOI 10.3109/03602537208993906

[9] ANTI-TUMOR 1-(X-ARYL)-3,3-DIALKYLTRIAZENES .1. QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS VS L1210 LEUKEMIA IN MICE [J].

HATHEWAY, GJ ;

HANSCH, C ;

KIM, KH ;

MILSTEIN, SR ;

SCHMIDT, CL ;

SMITH, RN ;

QUINN, FR .

JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (06) :563-574

[10] EFFECT OF N-NITROSO CARCINOGENS AND TRIAZENES ON PROTEIN-SYNTHESIS IN CELL-FREE SYSTEMS [J].

HRADEC, J ;

KOLAR, GF .

CHEMICO-BIOLOGICAL INTERACTIONS, 1974, 8 (04) :243-251

← 1 2 →